Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cidara Therapeutics Inc
CDTXCurrent price
13.24 USD
+1.03 USD (+8.44%)
Last closed
11.95 USD
Company
www.cidara.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
53 372 008 USD
Yield for 12 month
+1 308.66 %
1Y
3Y
5Y
10Y
15Y
CDTX
Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California. Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
81.25 USDP/E ratio
–Dividend Yield
–Current Year
+63 905 000 USD
Last Year
+64 288 000 USD
Current Quarter
+17 583 000 USD
Last Quarter
+17 583 000 USD
Current Year
+62 382 000 USD
Last Year
+64 288 000 USD
Current Quarter
+16 447 000 USD
Last Quarter
+16 447 000 USD
Key Figures CDTX
1 year
3 years
5 years
10 years
EBITDA
-37 839 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.29 %
PEG Ratio
–
Return On Equity TTM
-800.93 %
Wall Street Target Price
81.25 USD
Revenue TTM
46 261 000 USD
Book Value
-3.9 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-67.6 %
Dividend Yield
–
Gross Profit TTM
-11 232 000 USD
Earnings per share
-8.08 USD
Diluted Eps TTM
-8.08 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-78.4 %
Dividend Analytics CDTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CDTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
24.04.2024
Dividend Date
–
Stock Valuation CDTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
5.7504
Enterprise Value Revenue
0.5145
Price Sales TTM
1.2982
Enterprise Value EBITDA
-0.9542
Price Book MRQ
9.1318
Financials CDTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CDTX
For 52 weeks
10 USD
24.4 USD
50 Day MA
12.23 USD
Shares Short Prior Month
113 551
200 Day MA
14.31 USD
Short Ratio
2.27
Shares Short
111 513
Short Percent
2.84 %
BeatStart